Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy
JACC · 2024
DOI: 10.1016/j.jacc.2024.04.043 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JACC, 2024. Verfasst von Saad M Ezad und 18 weiteren Autor:innen. Beteiligte Einrichtung: British Heart Foundation Centre of Research Excellence at the School of Cardiovascular and Metabolic Medicine & Sciences, King's College London, Lond…. Hauptthemen laut MEDLINE: Myocardial Ischemia, Myocardial Revascularization. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, National Institute for Health and Care Research.
Abstract (Originalsprache)
BACKGROUND: Complete revascularization of coronary artery disease has been linked to improved outcomes in patients with preserved left ventricular (LV) function. OBJECTIVES: This study sought to identify the impact of complete revascularization in patients with severe LV dysfunction. METHODS: Patients enrolled in the REVIVED-BCIS2 (Revascularization for Ischemic Ventricular Dysfunction) trial were eligible if baseline/procedural angiograms and viability studies were available for analysis by independent core laboratories. Anatomical and viability-guided completeness of revascularization were measured by the coronary and myocardial revascularization indices (RIcoro and RImyo), respectively, where RIcoro = (change in British Cardiovascular Intervention Society Jeopardy score [BCIS-JS]) / (baseline BCIS-JS) and RImyo= (number of revascularized viable segments) / (number of viable segments supplied by diseased vessels). The percutaneous coronary intervention (PCI) group was classified as having complete or incomplete revascularization by median RIcoro and RImyo. The primary outcome was death or hospitalization for heart failure. RESULTS: Of 700 randomized patients, 670 were included. The baseline BCIS-JS and SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) scores were 8 (Q1-Q3: 6-10) and 22 (Q1-Q3: 15-29), respectively. In those patients assigned to PCI, median RIcoro and RImyo values were 67% and 85%, respectively. Compared with the group assigned to optimal medical therapy alone, there was no difference in the likelihood of the primary outcome in those patients receiving complete anatomical or viability-guided revascularization (HR: 0.90; 95% CI: 0.62-1.32; and HR: 0.95; 95% CI: 0.66-1.35, respectively). A sensitivity analysis by residual SYNTAX score showed no association with outcome. CONCLUSIONS: In patients with severe LV dysfunction, neither complete anatomical nor viability-guided revascularization was associated with improved event-free survival compared with incomplete revascularization or treatment with medical therapy alone. (Revascularization for Ischemic Ventricular Dysfunction) [REVIVED-BCIS2]; NCT01920048).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- British Heart Foundation Centre of Research Excellence at the School of Cardiovascular and Metabolic Medicine & Sciences, King's College London, London, United Kingdom.
- West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Clydebank, United Kingdom; Columbia University Medical Center, New York, New York, USA.
- Clinical Trials Unit, London School of Hygiene & Tropical Medicine, London, United Kingdom.
- West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Clydebank, United Kingdom.
- Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
- Barts Health NHS Trust, London, United Kingdom.
Förderung
- British Heart Foundation
- National Institute for Health and Care Research
Zitieren
APA
Ezad, S. M., McEntegart, M., Dodd, M., Didagelos, M., Sidik, N., Li Kam Wa, M., Morgan, H. P., Pavlidis, A., Weerackody, R., Walsh, S. J., Spratt, J. C., Strange, J., Ludman, P., Chiribiri, A., Clayton, T., Petrie, M. C., O'Kane, P., Perera, D., & REVIVED-BCIS2 Investigators (2024). Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy. JACC. https://doi.org/10.1016/j.jacc.2024.04.043
Vancouver
Ezad SM, McEntegart M, Dodd M, Didagelos M, Sidik N, Li Kam Wa M, et al. Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy. JACC. 2024. doi:10.1016/j.jacc.2024.04.043
BibTeX
@article{Ezad2024,
author = {Ezad, Saad M and McEntegart, Margaret and Dodd, Matthew and Didagelos, Matthaios and Sidik, Novalia and Li Kam Wa, Matthew and Morgan, Holly P and Pavlidis, Antonis and Weerackody, Roshan and Walsh, Simon J and Spratt, James C and Strange, Julian and Ludman, Peter and Chiribiri, Amedeo and Clayton, Tim and Petrie, Mark C and O'Kane, Peter and Perera, Divaka and REVIVED-BCIS2 Investigators, REVIVED-BCIS2 Investigators},
title = {Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy},
journal = {JACC},
year = {2024},
doi = {10.1016/j.jacc.2024.04.043}
}
EUVIMED